CHELSA STUBBS: Open Payments
NPI 1891456737 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 25 payments from 12 companies in 2025. Trend: 2023 $204 · 2024 $145 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $74 |
| Insmed, Inc. | 3 | $71 |
| Electromed, Inc. | 4 | $71 |
| GENZYME CORPORATION | 2 | $53 |
| Verona Pharma, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Philips North America LLC | 2 | $36 |
| Viatris Specialty LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: NUCALA, DUPIXENT, SMARTVEST, Ohtuvayre, Arikayce, Vest Therapy Und, YUPELRI, Brinsupri.
Industry payments across NC — which companies pay providers there.
